Soleus Capital Management, L.P. 10x Genomics, Inc. Transaction History
Soleus Capital Management, L.P.
- $1.18 Billion
- Q3 2024
A detailed history of Soleus Capital Management, L.P. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 951,000 shares of TXG stock, worth $13.9 Million. This represents 1.82% of its overall portfolio holdings.
Number of Shares
951,000
Previous 719,000
32.27%
Holding current value
$13.9 Million
Previous $14 Million
53.55%
% of portfolio
1.82%
Previous 1.42%
Shares
5 transactions
Others Institutions Holding TXG
# of Institutions
291Shares Held
94.7MCall Options Held
263KPut Options Held
85.1K-
Vanguard Group Inc Valley Forge, PA11MShares$160 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.8MShares$157 Million2.31% of portfolio
-
Morgan Stanley New York, NY6.48MShares$94.5 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$93.3 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.37MShares$93 Million1.67% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.39B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...